Skip to main content
PMC home page
Immunology logoLink to Immunology
. 1997 Mar;90(3):388–396. doi: 10.1111/j.1365-2567.1997.00388.x

Retinol (vitamin A) is a cofactor in CD3-induced human T-lymphocyte activation.

L M Allende 1, A Corell 1, A Madroño 1, R Góngora 1, C Rodríguez-Gallego 1, A López-Goyanes 1, M Rosal 1, A Arnaiz-Villena 1
PMCID: PMC1456614  PMID: 9155646

Abstract

Immunomodulatory effects of different retinoids have been demonstrated, both in vivo and in vitro, in different cellular lineages including human and murine thymocytes, human lung fibroblasts, Langerhans' cells, tumoral cells and natural killer (NK) cells; however, any attempt to demonstrate the effect of retinoids on human peripheral blood mononuclear cells (PBMC) resulted in negative results. In the present work, it is shown that retinol and retinoic acid induce a marked increase of proliferation on human PBMC from 32 unrelated healthy individuals, which had previously been stimulated with anti-CD3 antibodies 48 hr before. Serum-free medium, specific retinoid concentration (10(-7) M) and a particular timing of retinol addition to the cultures (48 hr after CD3 stimulation) was necessary clearly to detect this retinol-enhancing effect. The increased proliferative response is specifically mediated via the clonotipic T-cell receptor-CD3 complex and correlates with the up-regulation of certain adhesion/activation markers on the T-lymphocyte surface: CD18, CD45RO and CD25; also Th1-type of cytokines (interleukin-2 and interferon-gamma) are found concordantly increased after retinoid costimulation, both measured by a direct protein measurement and by a specific mRNA increase. In addition, it is shown that the in vitro retinol costimulation is only present in immunodeficient patients who have no defect on CD3 molecules and activation pathway. The fact that retinol costimulate lymphocytes only via CD3 (and not via CD2 or CD28) and the lack of response enhancement in immunodeficients with impaired CD3 activation pathway indicates that retinoids may be used as therapeutic agents in immune system deficiencies that do not affect the clonotypic T-cell receptor.

Full text

PDF
391

Images in this article

393Figure 5
on p.393

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abb J., Deinhardt F. Effects of retinoic acid on the human lymphocyte response to mitogens. Exp Cell Biol. 1980;48(3):169–179. doi: 10.1159/000162985. [DOI] [PubMed] [Google Scholar]
  2. Agura E. D., Howard M., Collins S. J. Identification and sequence analysis of the promoter for the leukocyte integrin beta-subunit (CD18): a retinoic acid-inducible gene. Blood. 1992 Feb 1;79(3):602–609. [PubMed] [Google Scholar]
  3. Beato M. Gene regulation by steroid hormones. Cell. 1989 Feb 10;56(3):335–344. doi: 10.1016/0092-8674(89)90237-7. [DOI] [PubMed] [Google Scholar]
  4. Biesinger B., Müller-Fleckenstein I., Simmer B., Lang G., Wittmann S., Platzer E., Desrosiers R. C., Fleckenstein B. Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci U S A. 1992 Apr 1;89(7):3116–3119. doi: 10.1073/pnas.89.7.3116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bissonnette R. P., Brunner T., Lazarchik S. B., Yoo N. J., Boehm M. F., Green D. R., Heyman R. A. 9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation. Mol Cell Biol. 1995 Oct;15(10):5576–5585. doi: 10.1128/mcb.15.10.5576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blomhoff R., Green M. H., Berg T., Norum K. R. Transport and storage of vitamin A. Science. 1990 Oct 19;250(4979):399–404. doi: 10.1126/science.2218545. [DOI] [PubMed] [Google Scholar]
  7. Blumberg B., Mangelsdorf D. J., Dyck J. A., Bittner D. A., Evans R. M., De Robertis E. M. Multiple retinoid-responsive receptors in a single cell: families of retinoid "X" receptors and retinoic acid receptors in the Xenopus egg. Proc Natl Acad Sci U S A. 1992 Mar 15;89(6):2321–2325. doi: 10.1073/pnas.89.6.2321. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Brockes J. Developmental biology. Reading the retinoid signals. Nature. 1990 Jun 28;345(6278):766–768. doi: 10.1038/345766a0. [DOI] [PubMed] [Google Scholar]
  9. Cantorna M. T., Nashold F. E., Hayes C. E. In vitamin A deficiency multiple mechanisms establish a regulatory T helper cell imbalance with excess Th1 and insufficient Th2 function. J Immunol. 1994 Feb 15;152(4):1515–1522. [PubMed] [Google Scholar]
  10. Carman J. A., Hayes C. E. Abnormal regulation of IFN-gamma secretion in vitamin A deficiency. J Immunol. 1991 Aug 15;147(4):1247–1252. [PubMed] [Google Scholar]
  11. Castaigne S., Chomienne C., Daniel M. T., Ballerini P., Berger R., Fenaux P., Degos L. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results. Blood. 1990 Nov 1;76(9):1704–1709. [PubMed] [Google Scholar]
  12. Clamon G., Chabot G. G., Valeriote F., Davilla E., Vogel C., Gorowski E., Birch R. Phase I study and pharmacokinetics of weekly high-dose 13-cis-retinoic acid. Cancer Res. 1985 Apr;45(4):1874–1878. [PubMed] [Google Scholar]
  13. Cope F. O., Howard B. D., Boutwell R. K. The in vitro characterization of the inhibition of mouse brain protein kinase-C by retinoids and their receptors. Experientia. 1986 Sep 15;42(9):1023–1027. doi: 10.1007/BF01940716. [DOI] [PubMed] [Google Scholar]
  14. Evans R. M. The steroid and thyroid hormone receptor superfamily. Science. 1988 May 13;240(4854):889–895. doi: 10.1126/science.3283939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Fanjul A., Dawson M. I., Hobbs P. D., Jong L., Cameron J. F., Harlev E., Graupner G., Lu X. P., Pfahl M. A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature. 1994 Nov 3;372(6501):107–111. doi: 10.1038/372107a0. [DOI] [PubMed] [Google Scholar]
  16. Fiedler-Nagy C., Wittreich B. H., Georgiadis A., Hope W. C., Welton A. F., Coffey J. W. Comparative study of natural and synthetic retinoids as inhibitors of arachidonic acid release and metabolism in rat peritoneal macrophages. Dermatologica. 1987;175 (Suppl 1):81–92. doi: 10.1159/000248864. [DOI] [PubMed] [Google Scholar]
  17. Formelli F., Carsana R., Costa A., Buranelli F., Campa T., Dossena G., Magni A., Pizzichetta M. Plasma retinol level reduction by the synthetic retinoid fenretinide: a one year follow-up study of breast cancer patients. Cancer Res. 1989 Nov 1;49(21):6149–6152. [PubMed] [Google Scholar]
  18. Friedman A., Halevy O., Schrift M., Arazi Y., Sklan D. Retinoic acid promotes proliferation and induces expression of retinoic acid receptor-alpha gene in murine T lymphocytes. Cell Immunol. 1993 Nov;152(1):240–248. doi: 10.1006/cimm.1993.1284. [DOI] [PubMed] [Google Scholar]
  19. Garbe A., Buck J., Hämmerling U. Retinoids are important cofactors in T cell activation. J Exp Med. 1992 Jul 1;176(1):109–117. doi: 10.1084/jem.176.1.109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Goodman D. S. Vitamin A and retinoids in health and disease. N Engl J Med. 1984 Apr 19;310(16):1023–1031. doi: 10.1056/NEJM198404193101605. [DOI] [PubMed] [Google Scholar]
  21. Góngora R., Corell A., Regueiro J. R., Carasol M., Rodríguez-Gallego C., Paz-Artal E., Timón M., Allende L., Arnaiz-Villena A. Peripheral blood reduction of memory (CD29+, CD45RO+, and "bright" CD2+ and LFA-1+) T lymphocytes in Papillon-Lefèvre syndrome. Hum Immunol. 1994 Nov;41(3):185–192. doi: 10.1016/0198-8859(94)90035-3. [DOI] [PubMed] [Google Scholar]
  22. Iwata M., Mukai M., Nakai Y., Iseki R. Retinoic acids inhibit activation-induced apoptosis in T cell hybridomas and thymocytes. J Immunol. 1992 Nov 15;149(10):3302–3308. [PubMed] [Google Scholar]
  23. Leid M., Kastner P., Lyons R., Nakshatri H., Saunders M., Zacharewski T., Chen J. Y., Staub A., Garnier J. M., Mader S. Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently. Cell. 1992 Jan 24;68(2):377–395. doi: 10.1016/0092-8674(92)90478-u. [DOI] [PubMed] [Google Scholar]
  24. Maden M. Biolistics. The retinoic acid supergun affair. Curr Biol. 1994 Mar 1;4(3):281–284. doi: 10.1016/s0960-9822(00)00066-x. [DOI] [PubMed] [Google Scholar]
  25. Mangelsdorf D. J., Umesono K., Kliewer S. A., Borgmeyer U., Ong E. S., Evans R. M. A direct repeat in the cellular retinol-binding protein type II gene confers differential regulation by RXR and RAR. Cell. 1991 Aug 9;66(3):555–561. doi: 10.1016/0092-8674(81)90018-0. [DOI] [PubMed] [Google Scholar]
  26. Meunier L., Bohjanen K., Voorhees J. J., Cooper K. D. Retinoic acid upregulates human Langerhans cell antigen presentation and surface expression of HLA-DR and CD11c, a beta 2 integrin critically involved in T-cell activation. J Invest Dermatol. 1994 Dec;103(6):775–779. doi: 10.1111/1523-1747.ep12413014. [DOI] [PubMed] [Google Scholar]
  27. Moore D. D. Diversity and unity in the nuclear hormone receptors: a terpenoid receptor superfamily. New Biol. 1990 Jan;2(1):100–105. [PubMed] [Google Scholar]
  28. Nicoletti I., Migliorati G., Pagliacci M. C., Grignani F., Riccardi C. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Methods. 1991 Jun 3;139(2):271–279. doi: 10.1016/0022-1759(91)90198-o. [DOI] [PubMed] [Google Scholar]
  29. Pérez-Aciego P., Alarcón B., Arnaiz-Villena A., Terhorst C., Timón M., Segurado O. G., Regueiro J. R. Expression and function of a variant T cell receptor complex lacking CD3-gamma. J Exp Med. 1991 Aug 1;174(2):319–326. doi: 10.1084/jem.174.2.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pérez-Blas M., Arnaiz-Villena A., Góngora R., Segurado O. G., Vivanco J. L., Regueiro J. R. Impaired T cell signal transduction through CD28 in a patient with idiopathic thrombocytopenia. Clin Exp Immunol. 1991 Sep;85(3):424–428. doi: 10.1111/j.1365-2249.1991.tb05743.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Racke M. K., Burnett D., Pak S. H., Albert P. S., Cannella B., Raine C. S., McFarlin D. E., Scott D. E. Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol. 1995 Jan 1;154(1):450–458. [PubMed] [Google Scholar]
  32. Regueiro J. R., López-Botet M., De Landazuri M. O., Alcami J., Corell A., Martín-Villa J. M., Vicario J. L., Arnaiz-Villena A. An in vivo functional immune system lacking polyclonal T-cell surface expression of the CD3/Ti(WT31) complex. Scand J Immunol. 1987 Dec;26(6):699–708. doi: 10.1111/j.1365-3083.1987.tb02306.x. [DOI] [PubMed] [Google Scholar]
  33. Ross A. C., Ternus M. E. Vitamin A as a hormone: recent advances in understanding the actions of retinol, retinoic acid, and beta carotene. J Am Diet Assoc. 1993 Nov;93(11):1285–1292. doi: 10.1016/0002-8223(93)91956-q. [DOI] [PubMed] [Google Scholar]
  34. Saxon A., Keld B., Braun J., Dotson A., Sidell N. Long-term administration of 13-cis retinoic acid in common variable immunodeficiency: circulating interleukin-6 levels, B-cell surface molecule display, and in vitro and in vivo B-cell antibody production. Immunology. 1993 Nov;80(3):477–487. [PMC free article] [PubMed] [Google Scholar]
  35. Semba R. D. Vitamin A, immunity, and infection. Clin Infect Dis. 1994 Sep;19(3):489–499. doi: 10.1093/clinids/19.3.489. [DOI] [PubMed] [Google Scholar]
  36. Sidell N., Chang B., Bhatti L. Upregulation by retinoic acid of interleukin-2-receptor mRNA in human T lymphocytes. Cell Immunol. 1993 Jan;146(1):28–37. doi: 10.1006/cimm.1993.1003. [DOI] [PubMed] [Google Scholar]
  37. Sidell N., Famatiga E., Golub S. H. Augmentation of human thymocyte proliferative responses by retinoic acid. Exp Cell Biol. 1981;49(5):239–245. doi: 10.1159/000163828. [DOI] [PubMed] [Google Scholar]
  38. Sidell N., Ramsdell F. Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. Cell Immunol. 1988 Sep;115(2):299–309. doi: 10.1016/0008-8749(88)90183-9. [DOI] [PubMed] [Google Scholar]
  39. Umesono K., Murakami K. K., Thompson C. C., Evans R. M. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell. 1991 Jun 28;65(7):1255–1266. doi: 10.1016/0092-8674(91)90020-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Villa M. L., Ferrario E., Trabattoni D., Formelli F., De Palo G., Magni A., Veronesi U., Clerici E. Retinoids, breast cancer and NK cells. Br J Cancer. 1993 Nov;68(5):845–850. doi: 10.1038/bjc.1993.443. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Vollberg T. M., Sr, Nervi C., George M. D., Fujimoto W., Krust A., Jetten A. M. Retinoic acid receptors as regulators of human epidermal keratinocyte differentiation. Mol Endocrinol. 1992 May;6(5):667–676. doi: 10.1210/mend.6.5.1318502. [DOI] [PubMed] [Google Scholar]
  42. Yang Y., Merćep M., Ware C. F., Ashwell J. D. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J Exp Med. 1995 May 1;181(5):1673–1682. doi: 10.1084/jem.181.5.1673. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Yang Y., Minucci S., Ozato K., Heyman R. A., Ashwell J. D. Efficient inhibition of activation-induced Fas ligand up-regulation and T cell apoptosis by retinoids requires occupancy of both retinoid X receptors and retinoic acid receptors. J Biol Chem. 1995 Aug 4;270(31):18672–18677. doi: 10.1074/jbc.270.31.18672. [DOI] [PubMed] [Google Scholar]
  44. Yang Y., Vacchio M. S., Ashwell J. D. 9-cis-retinoic acid inhibits activation-driven T-cell apoptosis: implications for retinoid X receptor involvement in thymocyte development. Proc Natl Acad Sci U S A. 1993 Jul 1;90(13):6170–6174. doi: 10.1073/pnas.90.13.6170. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Zitnik R. J., Kotloff R. M., Latifpour J., Zheng T., Whiting N. L., Schwalb J., Elias J. A. Retinoic acid inhibition of IL-1-induced IL-6 production by human lung fibroblasts. J Immunol. 1994 Feb 1;152(3):1419–1427. [PubMed] [Google Scholar]

Articles from Immunology are provided here courtesy of British Society for Immunology

RESOURCES